Pfizer (NYSE:PFE) recently presented groundbreaking findings in cancer research, particularly the first-in-human Phase 1 clinical study of the innovative MesoC2 drug at the ASCO Annual Meeting, and ...

Pfizer (NYSE: PFE) is a great example, with its shares down around 57% below the previous high. When a stock plunges as much ...

The MoU underscores a shared commitment to strengthening Abu Dhabi’s position as a global hub for healthcare innovation ...

Some five years into a pneumococcal vaccine patent dispute in South Korea, SK Bioscience has emerged victorious over Pfizer.

Moscicki previously served as the deputy center director for science operations at the FDA’s Center for Drug Evaluation and ...

Seongnam: SK bioscience, a global vaccine and biotech company, has announced that the Supreme Court of Korea has ruled in its ...

Dr. Nadine Tarcha, Medical Director at Pfizer Gulf, highlighted the company’s role in shaping the future of healthcare research through meaningful partnerships. “At Pfizer, we believe real-world data ...

Dr. Nadine Tarcha, Medical Director at Pfizer Gulf, highlighted the company’s role in shaping the future of healthcare research through meaningful partnerships. “At Pfizer, we believe real ...

Pfizer (NYSE:PFE) indicated plans to explore acquisitions or partnerships to add cardiometabolic assets, including weight loss therapies, to the pipeline, following a major trial setback this month.

The HIV Clinical Trials Market focuses on the systematic evaluation of novel antiretroviral therapies, combination regimens, long-acting injectables, and immunotherapeutic approaches to control and ...